Pfizer Announces Top-Line Results of ABRYSVO® for RSV in Immunocompromised Adults
Go back to Pfizer Announces Top-Line Results of ABRYSVO® for RSV in Immunocompromised Adults| Pfizer Inc. (NYSE: PFE) | Delayed: 28.01 -0.44 (1.55%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.45 | 52 Week High | $37.39 | |||
| Open | $28.02 | 52 Week Low | $28.25 | |||
| Day High | $28.15 | P/E | 16.98 | |||
| Day Low | $27.72 | EPS | $1.65 | |||
| Volume | 7,052,821 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 28.01 -0.44 (1.55%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.45 | 52 Week High | $37.39 | |||
| Open | $28.02 | 52 Week Low | $28.25 | |||
| Day High | $28.15 | P/E | 16.98 | |||
| Day Low | $27.72 | EPS | $1.65 | |||
| Volume | 7,052,821 | |||||
